2020 American Transplant Congress
Outcomes in Liver Transplantation with Use of Granulocyte-Colony Stimulating Factor
The Ohio State Wexner Medical Center, Columbus, OH
*Purpose: Questions remain if treatment with a granulocyte-colony stimulating factor (G-CSF) impacts clinical outcomes after liver transplant. The purpose of this study was to compare…2020 American Transplant Congress
Risk of Invasive Fungal Infection after Heart Transplantation
*Purpose: Invasive fungal infection (IFI) after heart transplantation is a feared complication associated with significant morbidity and mortality. Risk factors for invasive fungal infection after…2020 American Transplant Congress
Preoperative Antibody Titer Against BK Polyomavirus May Predict BK Polyomavirus-Associated Nephropathy after Kidney Transplantation
Urology, Akita University Hospital, Akita, Japan
*Purpose: BK polyomavirus (BKPyV) is a causative agent of BKPyV-associated nephropathy (BKPyV-AN) and hemorrhagic cystitis, which occurs subsequent to BKPyV reactivation. Intravenous immunoglobulin is presumed…2020 American Transplant Congress
Incidence and Effects of Posttransplant Herpes Zoster in Adult Solid Organ Transplant Recipients : A Meta-Analysis
Yonsei University Health System, Seoul, Korea, Republic of
*Purpose: Recently, non-live recombinant subunit HZ vaccine showed highly effective for herpes zoster (HZ) in hematopoietic stem cell transplantation. Several observational studies reported various features…2020 American Transplant Congress
Outpatient Treatment of Paramyxovirus with Oral Ribavirin is Safe and Effective in Lung Transplant Recipients
*Purpose: Respiratory paramyxovirus infections present an increased risk to lung transplant recipients (LTRs), including rapid decline in graft function and immunologic sequelae such as rejection…2020 American Transplant Congress
Effectiveness and Tolerability of Cidofovir for the Management of BK Viremia in Kidney Transplant Recipients
*Purpose: BK viremia (BKV) is a common complication after kidney transplantation (KT) that often leads to graft dysfunction and loss. Without consensus management guidelines and…2020 American Transplant Congress
Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population
Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of
*Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…2020 American Transplant Congress
Experience with a BKV-Specific, Neutralizing Monoclonal Antibody (MAU868) for Treatment of Severe BK Virus Nephropathy (BKVN) after Kidney Transplant (FDA EIND #139112)
*Purpose: BK viral reactivation leading to nephropathy and allograft loss in kidney transplant recipients remains a significant challenge. No effective BKV-therapies are currently available. Management…2020 American Transplant Congress
Testing Deceased Organ Donors for Infections: An Organ Procurement Organization (OPO) Survey
*Purpose: We surveyed the 58 U.S. OPOs to update our knowledge about the current methods of infectious disease testing in deceased organ donors.*Methods: An IRB…2020 American Transplant Congress
Risk of Tuberculosis in Kidney Transplantation Recipients Compared to Dialysis Patients or General Population: A Nationwide Cohort Study with Matched Controls
*Purpose: Risk of Mycobacterium tuberculosis (TB) infection has been reported to be increased in kidney transplant recipients. However, a nationwide cohort study from an Asian…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 84
- Next Page »